Cargando…

New opportunities with biologic treatments in pediatric allergic and respiratory diseases

In the last 20 years, the introduction of monoclonal antibodies has dramatically changed allergic diseases. At present, several monoclonal antibodies are approved for treating asthma, atopic dermatitis, chronic spontaneous urticaria, and chronic sinusitis with nasal polyps in children. Biologics hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenero, Laura, Piacentini, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305856/
https://www.ncbi.nlm.nih.gov/pubmed/35080293
http://dx.doi.org/10.1111/pai.13617